Physician profile
Aaron C Allred
NPI 1689929515
$500.70
in general payments reported to CMS, 2019-2025
11 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $364 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $207.71 | 2024 | Affinity, Apligraf |
| Kerecis Limited | $57.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $43.43 | 2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $42.01 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $41.70 | 2024 | Grafix, Collagenase Santyl, Regranex |
| Lifenet Health | $25.83 | 2025 | Theragenesis Wound Matrix |
| Abbvie INC. | $18.16 | 2025 | |
| Mimedx Group, INC. | $17.73 | 2025 | |
| Amgen INC. | $17.20 | 2024 | Krystexxa |
| Convatec INC. | $16.61 | 2024 | |
| Reprise Biomedical, INC. | $12.94 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.